Mirae Asset Global Investments Co., Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$22.5 Billion
Q3 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,496 shares of ARWR stock, worth $87,806. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,496

Previous 3,708 21.25%

Holding current value

$87,806

Previous $96,000 9.38%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$19.36 - $29.54 $15,255 - $23,277	788 Added 21.25%	4,496 $87,000
Q2 2024 Jul 30, 2024	SELL	$21.87 - $28.24 $7.09 Million - $9.15 Million	-324,074 Reduced 98.87%	3,708 $96,000
Q1 2024 May 01, 2024	BUY	$27.21 - $39.48 $3.59 Million - $5.2 Million	131,797 Added 67.25%	327,782 $9.37 Million
Q4 2023 Jan 24, 2024	SELL	$21.2 - $31.03 $2.17 Million - $3.18 Million	-102,385 Reduced 34.31%	195,985 $6 Million
Q3 2023 Oct 26, 2023	BUY	$26.2 - $36.08 $620,258 - $854,157	23,674 Added 8.62%	298,370 $8.02 Million
Q2 2023 Aug 10, 2023	SELL	$25.16 - $41.38 $1.41 Million - $2.32 Million	-55,962 Reduced 16.92%	274,696 $9.8 Million
Q1 2023 May 04, 2023	BUY	$23.68 - $38.51 $320,319 - $520,924	13,527 Added 4.27%	330,658 $8.4 Million
Q4 2022 Feb 09, 2023	BUY	$28.0 - $40.56 $1.79 Million - $2.6 Million	64,005 Added 25.29%	317,131 $12.9 Million
Q3 2022 Nov 10, 2022	BUY	$29.63 - $48.31 $1.09 Million - $1.78 Million	36,921 Added 17.08%	253,126 $8.37 Million
Q2 2022 Jul 26, 2022	BUY	$27.79 - $50.61 $1.85 Million - $3.37 Million	66,515 Added 44.44%	216,205 $7.61 Million
Q1 2022 May 10, 2022	SELL	$39.62 - $69.97 $1.08 Million - $1.91 Million	-27,235 Reduced 15.39%	149,690 $6.88 Million
Q4 2021 Feb 08, 2022	BUY	$58.09 - $82.51 $1.24 Million - $1.76 Million	21,336 Added 13.71%	176,925 $11.7 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $1.8 Million - $2.61 Million	30,753 Added 24.63%	155,589 $9.71 Million
Q2 2021 Aug 11, 2021	BUY	$62.15 - $90.32 $694,650 - $1.01 Million	11,177 Added 9.83%	124,836 $10.3 Million
Q1 2021 May 13, 2021	BUY	$61.35 - $90.47 $3.12 Million - $4.6 Million	50,865 Added 81.0%	113,659 $7.54 Million
Q4 2020 Feb 10, 2021	BUY	$43.82 - $85.37 $329,745 - $642,409	7,525 Added 13.62%	62,794 $4.82 Million
Q3 2020 Nov 12, 2020	BUY	$33.21 - $51.27 $507,946 - $784,174	15,295 Added 38.26%	55,269 $2.38 Million
Q2 2020 Aug 11, 2020	BUY	$26.12 - $43.27 $322,346 - $533,995	12,341 Added 44.66%	39,974 $1.73 Million
Q1 2020 May 12, 2020	BUY	$20.56 - $63.12 $111,908 - $343,562	5,443 Added 24.53%	27,633 $795,000
Q4 2019 Feb 12, 2020	SELL	$28.14 - $73.01 $121,114 - $314,235	-4,304 Reduced 16.25%	22,190 $1.41 Million
Q3 2019 Nov 12, 2019	BUY	$26.26 - $34.86 $491,928 - $653,032	18,733 Added 241.37%	26,494 $747,000
Q2 2019 Aug 13, 2019	BUY	$17.43 - $28.82 $135,274 - $223,672	7,761 New	7,761 $206,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.07B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History